• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Multidrug-resistant Escherichia fergusonii: a case of acute cystitis.多重耐药弗格森埃希菌:一例急性膀胱炎病例
J Clin Microbiol. 2008 Apr;46(4):1551-2. doi: 10.1128/JCM.01210-07. Epub 2008 Feb 6.
2
First description of an extended-spectrum-beta-lactamase-producing multidrug-resistant Escherichia fergusonii strain in a patient with cystitis.首次在膀胱炎患者中发现一株产超广谱β-内酰胺酶的多重耐药弗格森埃希菌。
J Clin Microbiol. 2010 Jun;48(6):2301-2. doi: 10.1128/JCM.00364-10. Epub 2010 Apr 21.
3
Escherichia fergusonii: an emerging pathogen in South Orissa.弗格森埃希菌:奥里萨邦南部一种新出现的病原体。
Indian J Med Microbiol. 2005 Jul;23(3):204. doi: 10.4103/0255-0857.16598.
4
Pathogenic and multidrug-resistant Escherichia fergusonii from broiler chicken.从肉鸡中分离出的致病性和多药耐药性弗格森埃希氏菌。
Poult Sci. 2012 Feb;91(2):512-25. doi: 10.3382/ps.2011-01738.
5
Isolation of Escherichia fergusonii from four different sites in a patient with pancreatic carcinoma and cholangiosepsis.从一名患有胰腺癌和胆管败血症的患者的四个不同部位分离出弗格森埃希菌。
J Clin Microbiol. 1993 Aug;31(8):2201-3. doi: 10.1128/jcm.31.8.2201-2203.1993.
6
Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?产超广谱β-内酰胺酶的菌株中,有多大比例可以用非碳青霉烯类β-内酰胺类药物治疗?
Med Mal Infect. 2014 May;44(5):235-7. doi: 10.1016/j.medmal.2014.03.006. Epub 2014 Apr 26.
7
Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.急性单纯性膀胱炎患者对甲氧苄啶-磺胺甲恶唑耐药的危险因素。
Antimicrob Agents Chemother. 2008 Mar;52(3):846-51. doi: 10.1128/AAC.01200-07. Epub 2007 Dec 17.
8
Emerging Escherichia pathogen.新兴的大肠杆菌病原体。
J Clin Microbiol. 2013 Aug;51(8):2785-6. doi: 10.1128/JCM.00983-13. Epub 2013 Jun 5.
9
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.厄他培南及其他抗菌药物对马德里患者尿液中分离出的产超广谱β-内酰胺酶肠杆菌的活性。
Rev Esp Quimioter. 2007 Sep;20(3):334-8.
10
Prevalence of beta-lactam nonsusceptible Gram-negative bacilli and use and interpretation of current susceptibility breakpoints: a survey of infectious disease physicians.β-内酰胺类药物不敏感革兰氏阴性杆菌的流行情况,以及当前药敏折点的使用和解释:传染病医生的调查。
Diagn Microbiol Infect Dis. 2011 Nov;71(3):316-9. doi: 10.1016/j.diagmicrobio.2011.07.013. Epub 2011 Sep 6.

引用本文的文献

1
Maternal Faecalibacterium pathobionts and low-fiber diets synergize to impact offspring health: implications for atopic dermatitis.母体致病性粪杆菌与低纤维饮食协同作用影响后代健康:对特应性皮炎的启示
Microbiome. 2025 Aug 29;13(1):192. doi: 10.1186/s40168-025-02194-8.
2
Eco-friendly silver nanoparticles from garlic: a novel therapeutic approach for treating wound infections.源自大蒜的环保型银纳米颗粒:一种治疗伤口感染的新型疗法。
Front Cell Infect Microbiol. 2025 Jun 30;15:1604507. doi: 10.3389/fcimb.2025.1604507. eCollection 2025.
3
Evidence Supporting Oral Hygiene Management by Owners through a Genetic Analysis of Dental Plaque Bacteria in Dogs.通过对犬牙菌斑细菌的基因分析支持主人进行口腔卫生管理的证据。
Vet Sci. 2024 Feb 19;11(2):96. doi: 10.3390/vetsci11020096.
4
Complete genomic analysis of phage Mangalyan infecting .对感染……的曼加里安噬菌体进行全基因组分析。 (原句中“infecting”后缺少具体内容)
Microbiol Resour Announc. 2024 Jan 17;13(1):e0096323. doi: 10.1128/mra.00963-23. Epub 2023 Dec 13.
5
Interplay of Gut Microbiota in Polycystic Ovarian Syndrome: Role of Gut Microbiota, Mechanistic Pathways and Potential Treatment Strategies.肠道微生物群在多囊卵巢综合征中的相互作用:肠道微生物群的作用、作用机制途径及潜在治疗策略
Pharmaceuticals (Basel). 2023 Jan 28;16(2):197. doi: 10.3390/ph16020197.
6
Avian strains of emerging pathogen are phylogenetically diverse and harbor the greatest AMR dissemination potential among different sources: Comparative genomic evidence.新兴病原体的禽类毒株在系统发育上具有多样性,并且在不同来源中具有最大的抗菌药物耐药性传播潜力:比较基因组学证据。
Front Microbiol. 2023 Jan 20;13:1080677. doi: 10.3389/fmicb.2022.1080677. eCollection 2022.
7
Potentially Virulent Multi-Drug Resistant Isolated from Inanimate Surface in a Medical University: as an Alternative for Bacterial Virulence Determination.从某医科大学无生命表面分离出的潜在毒力多重耐药菌:作为细菌毒力测定的替代方法
Diagnostics (Basel). 2023 Jan 11;13(2):279. doi: 10.3390/diagnostics13020279.
8
The first case of Escherichia fergusonii with biofilm in China and literature review.中国首例产黏大肠埃希菌生物膜感染病例及文献复习。
BMC Infect Dis. 2023 Jan 20;23(1):35. doi: 10.1186/s12879-023-07985-8.
9
Editing of a Specific Strain of Escherichia coli in the Mouse Gut Using Native Phages.利用天然噬菌体编辑小鼠肠道中的特定大肠杆菌菌株。
Microbiol Spectr. 2022 Dec 21;10(6):e0180422. doi: 10.1128/spectrum.01804-22. Epub 2022 Oct 27.
10
Genomic Characterization of Two Isolates Harboring Gene From Farm Environment.从农场环境中分离的两个携带基因的菌株的基因组特征。
Front Cell Infect Microbiol. 2022 May 26;12:774494. doi: 10.3389/fcimb.2022.774494. eCollection 2022.

本文引用的文献

1
Escherichia coli O157 somatic antigen is present in an isolate of E. fergusonii.弗格森埃希菌的一个分离株中存在大肠杆菌O157菌体抗原。
Curr Microbiol. 2006 Jun;52(6):482-6. doi: 10.1007/s00284-005-0447-6. Epub 2006 May 9.
2
Escherichia fergusonii: an emerging pathogen in South Orissa.弗格森埃希菌:奥里萨邦南部一种新出现的病原体。
Indian J Med Microbiol. 2005 Jul;23(3):204. doi: 10.4103/0255-0857.16598.
3
Cloning and sequencing of the beta-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus.阴沟肠杆菌、摩氏柠檬酸杆菌、韦氏柠檬酸杆菌、弗格森埃希菌和致癌肠杆菌β-内酰胺酶基因及周边DNA序列的克隆与测序
FEMS Microbiol Lett. 2002 Sep 24;215(1):81-7. doi: 10.1111/j.1574-6968.2002.tb11374.x.
4
Enteropathogenicity and antimicrobial susceptibility of new Escherichia spp.新型埃希氏菌属的肠道致病性及抗菌药敏性
J Diarrhoeal Dis Res. 1999 Jun;17(2):85-7.
5
Isolation of Escherichia fergusonii from four different sites in a patient with pancreatic carcinoma and cholangiosepsis.从一名患有胰腺癌和胆管败血症的患者的四个不同部位分离出弗格森埃希菌。
J Clin Microbiol. 1993 Aug;31(8):2201-3. doi: 10.1128/jcm.31.8.2201-2203.1993.
6
Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens.费氏埃希菌和泰勒肠杆菌,从临床标本中分离出的肠杆菌科两个新菌种。
J Clin Microbiol. 1985 Jan;21(1):77-81. doi: 10.1128/jcm.21.1.77-81.1985.
7
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.从临床标本中分离出的肠杆菌科新物种和生物群的生化鉴定。
J Clin Microbiol. 1985 Jan;21(1):46-76. doi: 10.1128/jcm.21.1.46-76.1985.
8
Isolation of Escherichia fergosonii from a patient with septicemia in France.在法国从一名败血症患者体内分离出费氏埃希菌。
Eur J Clin Microbiol. 1987 Feb;6(1):78. doi: 10.1007/BF02097203.
9
Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.产超广谱β-内酰胺酶导致肠杆菌科细菌对新型β-内酰胺类药物产生可转移耐药性:医院流行情况及药敏模式
Rev Infect Dis. 1988 Jul-Aug;10(4):867-78. doi: 10.1093/clinids/10.4.867.

多重耐药弗格森埃希菌:一例急性膀胱炎病例

Multidrug-resistant Escherichia fergusonii: a case of acute cystitis.

作者信息

Savini Vincenzo, Catavitello Chiara, Talia Marzia, Manna Assunta, Pompetti Franca, Favaro Marco, Fontana Carla, Febbo Fabio, Balbinot Andrea, Di Berardino Fabio, Di Bonaventura Giovanni, Di Zacomo Silvia, Esattore Francesca, D'Antonio Domenico

机构信息

Vincenzo Savini, Unità Operativa Complessa di Microbiologia e Virologia Clinica, Dipartimento di Medicina Trasfusionale, Ospedale Civile Spirito Santo, via Fonte Romana 8, 65100, Pescara, Italy.

出版信息

J Clin Microbiol. 2008 Apr;46(4):1551-2. doi: 10.1128/JCM.01210-07. Epub 2008 Feb 6.

DOI:10.1128/JCM.01210-07
PMID:18256229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2292955/
Abstract

We report a case in which Escherichia fergusonii, an emerging pathogen in various types of infections, was associated with cystitis in a 52-year-old woman. The offending strain was found to be multidrug resistant. Despite in vitro activity, beta-lactam treatment failed because of a lack of patient compliance with therapy. The work confirms the pathogenic potential of E. fergusonii.

摘要

我们报告了一例病例,一名52岁女性患膀胱炎,其病因是费氏埃希菌,这是一种在各类感染中逐渐崭露头角的病原体。发现致病菌株具有多重耐药性。尽管β-内酰胺类药物在体外有活性,但由于患者未遵守治疗方案,治疗失败。这项研究证实了费氏埃希菌的致病潜力。